References
- Wang JM, Ram S, Labaki WW, Han MK, Galbán CJ. CT-based commercial software applications: improving patient care through accurate COPD subtyping. Int J Chron Obstruct Pulmon Dis. 2022;17:919–930. doi:10.2147/COPD.S334592
- Hull JH, Lloyd JK, Cooper BG. Lung function testing in the COVID-19 endemic. Lancet Respir Med. 2020;8:666–667. doi:10.1016/S2213-2600(20)30246-0
- Teramoto S. Japan famous comedian with COPD was killed by SARS-CoV-2-caused pneumonia –implication for smoking risk and ECMO indication. Int Clin Med. 2020;4:1–2. doi:10.15761/ICM.1000180
- da Silva SMD, Paschoal I, De Capitani E, et al. COPD phenotypes on computed tomography and its correlation with selected lung function variables in severe patients. Int J Chron Obstruct Pulmon Dis. 2016;11:503–513. doi:10.2147/COPD.S90638
- Barr RG, Berkowitz EA, Bigazzi F, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012;9:151–159. doi:10.3109/15412555.2012.654923
- Shaker SB, Stavngaard T, Laursen LC, Stoel BC, Dirksen A. Rapid fall in lung density following smoking cessation in COPD. COPD. 2011;8:2–7. doi:10.3109/15412555.2010.541306
- Teramoto S, Yamamoto H, Yamaguchi Y, Matsuse T, Ouchi Y. Global burden of COPD in Japan and Asia. Lancet. 2003;362(9397):1764–1765. doi:10.1016/S0140-6736(03)14865-9